chr3-159989102-G-A

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_000882.4(IL12A):​c.46G>A​(p.Ala16Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 32)

Consequence

IL12A
NM_000882.4 missense

Scores

1
16

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.117
Variant links:
Genes affected
IL12A (HGNC:5969): (interleukin 12A) This gene encodes a subunit of a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. The cytokine is a disulfide-linked heterodimer composed of the 35-kD subunit encoded by this gene, and a 40-kD subunit that is a member of the cytokine receptor family. This cytokine is required for the T-cell-independent induction of interferon (IFN)-gamma, and is important for the differentiation of both Th1 and Th2 cells. The responses of lymphocytes to this cytokine are mediated by the activator of transcription protein STAT4. Nitric oxide synthase 2A (NOS2A/NOS2) is found to be required for the signaling process of this cytokine in innate immunity. [provided by RefSeq, Jul 2008]
IL12A-AS1 (HGNC:49094): (IL12A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.034918964).
BP6
Variant 3-159989102-G-A is Benign according to our data. Variant chr3-159989102-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3109064.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IL12ANM_000882.4 linkuse as main transcriptc.46G>A p.Ala16Thr missense_variant 1/7
IL12ANM_001397992.1 linkuse as main transcriptc.-57G>A 5_prime_UTR_variant 1/7 ENST00000699704.1
IL12A-AS1NR_108088.1 linkuse as main transcriptn.1345C>T non_coding_transcript_exon_variant 9/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IL12AENST00000699704.1 linkuse as main transcriptc.-57G>A 5_prime_UTR_variant 1/7 NM_001397992.1 P1
IL12A-AS1ENST00000497452.5 linkuse as main transcriptn.1345C>T non_coding_transcript_exon_variant 9/102

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 30, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
8.0
DANN
Benign
0.92
DEOGEN2
Benign
0.010
T;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.53
T;T;T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.035
T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.090
N;N;N
REVEL
Benign
0.021
Sift
Benign
0.65
.;T;T
Sift4G
Benign
0.69
T;D;T
Polyphen
0.0
B;.;.
Vest4
0.090
MutPred
0.14
Gain of phosphorylation at A16 (P = 0.0092);Gain of phosphorylation at A16 (P = 0.0092);Gain of phosphorylation at A16 (P = 0.0092);
MVP
0.15
MPC
0.33
ClinPred
0.45
T
GERP RS
1.2
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-159706889; API